Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

Event Details

Q4 2020 Agios Pharmaceuticals Inc Earnings Conference Call

Feb 25, 2021 at 8:00 AM EST

Webcast Presentation

Title
Q4 2020 Agios Pharmaceuticals Inc Earnings Conference Call
Date / Time
Feb 25, 2021 at 8:00 AM EST